Formulary Chapter 9: Nutrition and blood - Full Chapter
|
09.06.04 |
Vitamin D |
|
|
Colecalciferol and Calcium Carbonate (Calci-D®)
|
First Choice
|
Calci-D is the most cost-effective calcium and vitamin D preparation. See Prescribing Points Dec 2016. Available as a chewable tablet (1 tablet daily).
|
|
Colecalciferol and Calcium Carbonate (Accrete-D3®)
|
Second Choice
|
|
|
Colecalciferol and Calcium Carbonate (Adacl D3® Caplets)
|
Third Choice
|
|
|
Colecalciferol and Calcium Carbonate (Adacl D3®) (Effervescent tablets)
|
Formulary
|
|
|
Colecalciferol and Calcium Carbonate (Adcal-D3®)
|
Formulary
|
Chewable tablets.
|
|
Colecalciferol and Calcium Carbonate (Calceos®)
|
Formulary
|
Chewable tablets.
|
|
Colecalciferol and Calcium Carbonate (Calcichew D3® Forte)
|
Formulary
|
Chewable tablets.
|
|
Colecalciferol and Calcium Carbonate (Natecal D3®)
|
Formulary
|
Chewable tablets.
|
|
Ergocalciferol (Injection)
|
Formulary
|
Secondary care use only.
|
|
Alfacalcidol (One-Alpha®)
|
Formulary
|
Suitable for prescribing in primary care following specialist recommendation.
|
|
Calcitriol
|
Formulary
|
Suitable for prescribing in primary care following specialist recommendation.
|
|
Colecalciferol 1000 unit capsules/ tablets (Fultium-D3®, Desunin®)
|
Restricted
|
Available to purchase over the counter so only prescribe in patients with established osteopenia or osteoporosis or on advice of renal unit, in line with Clinical Commissioning Policy 88D.
For vitamin D deficiency in line with Pathway for Treating Vitamin D Deficiency in Adults (APCO January 2021).
Also see Vitamin D Supplementation in Pregnancy Guidelines and Vitamin D Supplementation in Pregnancy Algorithm (APCO September 2017).
|
|
Colecalciferol 800 unit capsules/ tablets (Strivit D3®, Invita D3®, Fultium-D3®, Desunin®)
|
Restricted
|
*Strivit D3® is the first line choice in Oxfordshire as it is the most cost-effective*
Strivit D3®, Invita D3®, Fultium D3® and Desunin® 800IU are prescription only medicines. However patients can be advised to purchase alternative preparations over the counter so only prescribe in patients with established osteopenia or osteoporosis or on advice of renal unit, in line with Clinical Commissioning Policy 88D.
For vitamin D deficiency in line with Pathway for Treating Vitamin D Deficiency in Adults (APCO January 2021).
Also see Vitamin D Supplementation in Pregnancy Guidelines and Vitamin D Supplementation in Pregnancy Algorithm (APCO September 2017).
|
|
Colecalciferol 2,740units/ml drops (Fultium-D3® Drops)
|
Formulary
|
For vitamin D deficiency in line with Pathway for Treating Vitamin D Deficiency in Adults (APCO January 2021).
Also see Vitamin D Supplementation in Pregnancy Guidelines and Vitamin D Supplementation in Pregnancy Algorithm (APCO September 2017).
NB. 3 drops contain 200 units.
|
|
Colecalciferol 20,000 unit capsules (Strivit D3®, Plenachol®, Aviticol®, Fultium-D3®)
|
Formulary
|
*Strivit D3® is the first line choice in Oxfordshire as it is the most cost-effective*
For vitamin D deficiency in line with Pathway for Treating Vitamin D Deficiency in Adults (APCO January 2021).
Also see Vitamin D Supplementation in Pregnancy Guidelines and Vitamin D Supplementation in Pregnancy Algorithm (APCO September 2017).
|
|
Colecalciferol 2000 units/ml drops (SunVit-D3® Drops)
|
Formulary
|
For vitamin D deficiency in line with Pathway for Treating Vitamin D Deficiency in Adults (APCO January 2021).
Also see Vitamin D Supplementation in Pregnancy Guidelines and Vitamin D Supplementation in Pregnancy Algorithm (APCO September 2017).
NB. 1 drop contain 100 units.
|
|
Colecalciferol 25,000 unit liquid (Invita D3® )
|
Formulary
|
For vitamin D deficiency in line with Pathway for Treating Vitamin D Deficiency in Adults (APCO January 2021).
Also see Vitamin D Supplementation in Pregnancy Guidelines and Vitamin D Supplementation in Pregnancy Algorithm (APCO September 2017).
|
|
Colecalciferol 3200 unit capsules (Strivit D3®, Fultium-D3®)
|
Formulary
|
*Strivit D3® is the first line choice in Oxfordshire as it is the most cost effective*
For vitamin D deficiency in line with Pathway for Treating Vitamin D Deficiency in Adults (APCO January 2021).
Also see Vitamin D Supplementation in Pregnancy Guidelines and Vitamin D Supplementation in Pregnancy Algorithm (APCO September 2017).
|
|
Colecalciferol 40,000 unit capsules (Plenachol®)
|
Formulary
|
For vitamin D deficiency in line with Pathway for Treating Vitamin D Deficiency in Adults (APCO September 2016).
Also see Vitamin D Supplementation in Pregnancy Guidelines and Vitamin D Supplementation in Pregnancy Algorithm (APCO September 2017).
|
|
|
|
|
|
|
|
|
|
|
|
|
.... |
Non Formulary Items |
Calcium and Ergocalciferol

|
Non Formulary
|
|
|
Calcium Carbonate with Colecalciferol

|
Non Formulary
|
|
|
Colecalciferol (With alendronic acid )

|
Non Formulary
|
|
|
Colecalciferol 10,000units/ml drops (Thorens®)

|
Non Formulary
|
|
|
Colecalciferol 2,400 units/ml drops (Invita D3® oral drops)

|
Non Formulary
|
|
|
Colecalciferol 3,000 units per ml liquid

|
Non Formulary
|
|
|
Colecalciferol and Calcium Carbonate

|
Non Formulary
|
|
|
Colecalciferol and Calcium Carbonate (Cacit-D3®)

|
Non Formulary
|
Effervescent granules in sachets. |
|
Colecalciferol and Calcium Carbonate (Calcichew D3®)

|
Non Formulary
|
|
|
Colecalciferol and Calcium Carbonate (Calcichew D3® 500mg/400unit Caplets)

|
Non Formulary
|
|
|
Colecalciferol and Calcium Carbonate (Calcichew-D3 Once Daily)

|
Non Formulary
|
|
|
Colecalciferol with Calcium carbonate (Kalcipos-D®)

|
Non Formulary
|
The amount of calcium is less than the usual recommended intake. More cost effective preparations available. APCO September 2011. |
|
Dihydrotachysterol (AT 10®)

|
Non Formulary
|
|
|
Ergocalciferol (Oral)

|
Non Formulary
|
|
|
Ergocalciferol (Calfovit D3®)

|
Non Formulary
|
|
|
Paricalcitol (Zemplar®)

|
Non Formulary
|
|
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
Status |
Description |

|
Red: Medicines which should only be prescribed in secondary care by a specialist. |

|
Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred. |

|
Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO). |

|
Green: Medicines which are suitable for initiation and ongoing prescribing within primary care. |

|
Brown: Medicines which should only be prescribed in restricted circumstances. |

|
Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety. |

|
not used |
|
|
|